SAN DIEGO, February 3, 2021 / PRNewswire / - ViaCyte, Inc., a clinical-stage regenerative medicine company, announced today that the first patients with...
Editors: David L. Joffe, BSPharm, CDE, FACA
How safe and effective is that first commercial configuration of a tubeless automated insulin delivery system, Omnipod...